Literature DB >> 26603091

Low prevalence of unexpected popliteal DVT detected on routine MRI assessment of the knee.

Ryan M Shulman1, Craig Buchan2, Robert R Bleakney3, Lawrence M White4.   

Abstract

OBJECTIVE: The purpose of this study was to document the appearance and determine the prevalence of findings suspicious for popliteal vein thrombosis on magnetic resonance (MR) assessment of the knee joint.
METHODS: A total of 2888 MR examinations were retrospectively reviewed and classified as illustrating either normal appearing popliteal vein or findings suspicious for popliteal vein thrombosis.
RESULTS: A total of 2879 MR studies were assessed as having a normal appearing popliteal vein. Nine studies illustrated findings suspicious for popliteal vein thrombosis.
CONCLUSION: Although the prevalence of MR findings is low (0.3%), our findings reiterate the need to interrogate the popliteal vein for evidence of thrombosis.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  DVT; Incidental; Internal derangement of the knee; MRI; Popliteal vein

Mesh:

Year:  2015        PMID: 26603091     DOI: 10.1016/j.clinimag.2015.09.008

Source DB:  PubMed          Journal:  Clin Imaging        ISSN: 0899-7071            Impact factor:   1.605


  3 in total

1.  Deep vein thrombosis is accurately predicted by comprehensive analysis of the levels of microRNA-96 and plasma D-dimer.

Authors:  Xuesheng Xie; Changpeng Liu; Wei Lin; Baoming Zhan; Changjun Dong; Zhen Song; Shilei Wang; Yingguo Qi; Jiali Wang; Zengquan Gu
Journal:  Exp Ther Med       Date:  2016-07-26       Impact factor: 2.447

2.  IQCA-TAVV: To explore the effect of P-selectin, GPIIb/IIIa, IL-2, IL-6 and IL-8 on deep venous thrombosis.

Authors:  Jianhui Wu; Haimei Zhu; Guodong Yang; Yuji Wang; Yaonan Wang; Shurui Zhao; Ming Zhao; Shiqi Peng
Journal:  Oncotarget       Date:  2017-08-24

3.  Prevalence and risk factors of deep venous thrombosis in patients with longitudinally extensive transverse myelitis: one center data from China.

Authors:  Tian Song; Xindi Li; Yonghong Liu; Xinghu Zhang
Journal:  BMC Neurol       Date:  2018-10-30       Impact factor: 2.474

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.